Director of Alignment Healthcare (ALHC.US) Proposes Sale of $10.23 Million in Common Stock via Form 144
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 07 2026
0mins
Should l Buy ALHC?
Source: moomoo
Share Sale Announcement: JEK Trust U/ADTD plans to sell 548,000 shares of Alignment Health Care (ALHC) on April 7, with an estimated market value of approximately $10.23 million.
Reduction in Shareholding: Since January 12, 2026, JEK Trust U/ADTD has reduced its shareholding in Alignment Health Care by 779,950 shares, valued at around $14.98 million.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ALHC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ALHC
Wall Street analysts forecast ALHC stock price to rise
9 Analyst Rating
7 Buy
2 Hold
0 Sell
Strong Buy
Current: 21.220
Low
18.00
Averages
21.81
High
30.00
Current: 21.220
Low
18.00
Averages
21.81
High
30.00
About ALHC
Alignment Healthcare, Inc. is a consumer-centric platform designed to improve the healthcare experience for seniors. The Company’s operations primarily consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. It partners with local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology (AVA). AVA’s capabilities include consumer experience, internal care delivery, external providers, health plan operations and growth operations. AVA offers a digital ecosystem that enables its members and their support system to get the information and care they need, when and how they need it. With their AVA-powered member portal and mobile app, seniors have many self-service capabilities and can get 24/7 care, send secure messages to their concierge and care teams, check their rewards and ACCESS On-Demand Concierge Card balance, and view their health history.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Analysis of Alignment Healthcare Executive Stock Transaction
- Transaction Overview: Dawn Christine Maroney, President of Alignment Healthcare, sold 30,000 shares of common stock on April 15, 2026, for a total value of $626,199, leaving her with 1,028,813 shares valued at approximately $21.5 million, indicating her ongoing engagement in the market.
- Trading Pattern Analysis: This sale aligns with Maroney's established monthly selling pattern and is below her historical average of 63,700 shares per sale, reflecting a trend of reduced holdings that may influence investor confidence.
- Shareholder Alignment: Post-transaction, Maroney retains about 0.50% ownership, ensuring alignment with shareholders and indicating her sustained confidence in the company's future prospects.
- Future Performance Outlook: Alignment Healthcare projects 2026 revenue between $5.14 billion and $5.19 billion, representing a 30% to 31% increase from the previous year, showcasing the company's positive trajectory in improving profitability and competitive positioning.
See More
Alignment CEO Sells 250,000 Shares
- Executive Share Sale: On April 7, 2026, Alignment's CEO John E Kao sold 250,000 shares, which may indicate a cautious outlook on the company's future performance, potentially negatively impacting investor confidence.
- Market Reaction Anticipation: Such executive sell-offs often lead to speculation regarding internal company information, causing investors to question Alignment's future performance, which could result in stock price volatility.
- Shareholding Structure Shift: This sale may prompt a reassessment of Alignment's shareholding structure in the market, particularly in light of executive sell-offs, raising concerns about corporate governance and transparency.
- Investor Confidence Challenge: Kao's sale could lead investors to doubt the company's long-term strategy and growth prospects, especially in the current market environment, potentially affecting the company's ability to raise funds and deliver shareholder returns.
See More
Alignment Healthcare Shares Surge 16.01% on Medicare Rate Increase
- Policy Boost: Alignment Healthcare's stock surged 16.01% on Tuesday, closing at $21.66 per share, as investors celebrated the higher reimbursement rates for Medicare Advantage plans, expected to yield over $13 billion in additional payments.
- Significant Rate Increase: The Centers for Medicare & Medicaid Services (CMS) reported a net average increase of 2.48% for next year's Medicare Advantage policies, a substantial rise from the 0.09% announced in January, which will directly impact the company's revenue growth.
- Optimistic Financial Outlook: Alignment Healthcare anticipates reporting first-quarter earnings with revenue targets between $5.135 billion and $5.190 billion, alongside health plan membership projections of 292,000 to 298,000, indicating robust growth potential in the market.
- Market Competition Insight: While there is optimism regarding ALHC as an investment, analysts suggest that certain AI stocks may offer greater upside potential and lower downside risk, reflecting a diverse focus on various investment opportunities in the market.
See More
Medicare Update Boosts Health Insurers' Stocks
- Payment Growth Expectations: The government now anticipates a 2.48% increase in Medicare payments for 2027, a significant rise from the previously projected 0.09%, which directly influences insurers' pricing strategies and profit margins, potentially leading to a reevaluation of related stocks.
- Strong Stock Reactions: Following the announcement, Alignment Healthcare's stock surged by 12.5%, Humana rose by 11%, and UnitedHealth increased by 7.8%, while Elevance and Centene saw gains of 6.7% and 4.3%, respectively, reflecting investor optimism about future profitability.
- Market Sentiment Shift: This update has shifted investor expectations for the Medicare sector, which had been bracing for a tighter environment, and the new data provides insurers with more operational breathing room, potentially fostering overall industry recovery.
- Fundamental Disparities: Despite the positive market sentiment, fundamental performance varies across the sector, with quantitative scores indicating that some companies still face challenges, prompting investors to carefully assess each company's financial health.
See More
Director of Alignment Healthcare (ALHC.US) Proposes Sale of $10.23 Million in Common Stock via Form 144
Share Sale Announcement: JEK Trust U/ADTD plans to sell 548,000 shares of Alignment Health Care (ALHC) on April 7, with an estimated market value of approximately $10.23 million.
Reduction in Shareholding: Since January 12, 2026, JEK Trust U/ADTD has reduced its shareholding in Alignment Health Care by 779,950 shares, valued at around $14.98 million.
See More
Surprise Increase in Medicare Advantage Payment Rates Boosts Healthcare Stocks
- Medicare Payment Rate Increase: The government unexpectedly raised payment rates for Medicare Advantage plans, increasing the federal funds received per patient by insurance companies, which is projected to enhance profit margins for major providers like UnitedHealth and Humana.
- Alignment Healthcare Stock Surge: Alignment Healthcare (NASDAQ:ALHC) shares jumped 18.7%, reflecting a strong market reaction to the company's outlook, with 26 moves greater than 5% in the past year indicating significant market perception shifts due to this news.
- Market Rally: The increase in Medicare payment rates boosted overall market confidence, leading to significant gains in major indices like the S&P 500 and Dow Jones Industrial Average, which in turn spurred widespread buying activity in major healthcare stocks.
- Investment Return Analysis: Alignment Healthcare has risen 9.3% since the beginning of the year, trading at $22.11, close to its 52-week high of $23.81 from January 2026, with a five-year investment of $1,000 now worth $1,016, demonstrating its long-term investment value.
See More
Analysis of Alignment Healthcare Executive Stock Transaction
- Transaction Overview: Dawn Christine Maroney, President of Alignment Healthcare, sold 30,000 shares of common stock on April 15, 2026, for a total value of $626,199, leaving her with 1,028,813 shares valued at approximately $21.5 million, indicating her ongoing engagement in the market.
- Trading Pattern Analysis: This sale aligns with Maroney's established monthly selling pattern and is below her historical average of 63,700 shares per sale, reflecting a trend of reduced holdings that may influence investor confidence.
- Shareholder Alignment: Post-transaction, Maroney retains about 0.50% ownership, ensuring alignment with shareholders and indicating her sustained confidence in the company's future prospects.
- Future Performance Outlook: Alignment Healthcare projects 2026 revenue between $5.14 billion and $5.19 billion, representing a 30% to 31% increase from the previous year, showcasing the company's positive trajectory in improving profitability and competitive positioning.
See More
Alignment CEO Sells 250,000 Shares
- Executive Share Sale: On April 7, 2026, Alignment's CEO John E Kao sold 250,000 shares, which may indicate a cautious outlook on the company's future performance, potentially negatively impacting investor confidence.
- Market Reaction Anticipation: Such executive sell-offs often lead to speculation regarding internal company information, causing investors to question Alignment's future performance, which could result in stock price volatility.
- Shareholding Structure Shift: This sale may prompt a reassessment of Alignment's shareholding structure in the market, particularly in light of executive sell-offs, raising concerns about corporate governance and transparency.
- Investor Confidence Challenge: Kao's sale could lead investors to doubt the company's long-term strategy and growth prospects, especially in the current market environment, potentially affecting the company's ability to raise funds and deliver shareholder returns.
See More
Alignment Healthcare Shares Surge 16.01% on Medicare Rate Increase
- Policy Boost: Alignment Healthcare's stock surged 16.01% on Tuesday, closing at $21.66 per share, as investors celebrated the higher reimbursement rates for Medicare Advantage plans, expected to yield over $13 billion in additional payments.
- Significant Rate Increase: The Centers for Medicare & Medicaid Services (CMS) reported a net average increase of 2.48% for next year's Medicare Advantage policies, a substantial rise from the 0.09% announced in January, which will directly impact the company's revenue growth.
- Optimistic Financial Outlook: Alignment Healthcare anticipates reporting first-quarter earnings with revenue targets between $5.135 billion and $5.190 billion, alongside health plan membership projections of 292,000 to 298,000, indicating robust growth potential in the market.
- Market Competition Insight: While there is optimism regarding ALHC as an investment, analysts suggest that certain AI stocks may offer greater upside potential and lower downside risk, reflecting a diverse focus on various investment opportunities in the market.
See More
Medicare Update Boosts Health Insurers' Stocks
- Payment Growth Expectations: The government now anticipates a 2.48% increase in Medicare payments for 2027, a significant rise from the previously projected 0.09%, which directly influences insurers' pricing strategies and profit margins, potentially leading to a reevaluation of related stocks.
- Strong Stock Reactions: Following the announcement, Alignment Healthcare's stock surged by 12.5%, Humana rose by 11%, and UnitedHealth increased by 7.8%, while Elevance and Centene saw gains of 6.7% and 4.3%, respectively, reflecting investor optimism about future profitability.
- Market Sentiment Shift: This update has shifted investor expectations for the Medicare sector, which had been bracing for a tighter environment, and the new data provides insurers with more operational breathing room, potentially fostering overall industry recovery.
- Fundamental Disparities: Despite the positive market sentiment, fundamental performance varies across the sector, with quantitative scores indicating that some companies still face challenges, prompting investors to carefully assess each company's financial health.
See More
Director of Alignment Healthcare (ALHC.US) Proposes Sale of $10.23 Million in Common Stock via Form 144
Share Sale Announcement: JEK Trust U/ADTD plans to sell 548,000 shares of Alignment Health Care (ALHC) on April 7, with an estimated market value of approximately $10.23 million.
Reduction in Shareholding: Since January 12, 2026, JEK Trust U/ADTD has reduced its shareholding in Alignment Health Care by 779,950 shares, valued at around $14.98 million.
See More
Surprise Increase in Medicare Advantage Payment Rates Boosts Healthcare Stocks
- Medicare Payment Rate Increase: The government unexpectedly raised payment rates for Medicare Advantage plans, increasing the federal funds received per patient by insurance companies, which is projected to enhance profit margins for major providers like UnitedHealth and Humana.
- Alignment Healthcare Stock Surge: Alignment Healthcare (NASDAQ:ALHC) shares jumped 18.7%, reflecting a strong market reaction to the company's outlook, with 26 moves greater than 5% in the past year indicating significant market perception shifts due to this news.
- Market Rally: The increase in Medicare payment rates boosted overall market confidence, leading to significant gains in major indices like the S&P 500 and Dow Jones Industrial Average, which in turn spurred widespread buying activity in major healthcare stocks.
- Investment Return Analysis: Alignment Healthcare has risen 9.3% since the beginning of the year, trading at $22.11, close to its 52-week high of $23.81 from January 2026, with a five-year investment of $1,000 now worth $1,016, demonstrating its long-term investment value.
See More
